In this episode of Still Here: A two-way between Felicity Nelson and Betsy Ladyzhets comparing and contrasting the BC 007 and rapamycin Long COVID and ME clinical trial designs.

The transcript for this episode can be ⁠⁠found on our website⁠⁠, or jump to a specific part of the podcast below:

(00:00:00) Intro

(00:01:15) 2-way: Long COVID clinical trial design, BC 007 and rapamycin

(00:27:47) Outro

-

Mentioned in this episode (in order of appearance):

• The Sick Times: Clinical trials are testing cancer drug rapamycin for Long COVID and ME
• The Sick Times: Berlin Cures’ failed Long COVID clinical trial yields lessons on study design
• Research Square: Simmaron preprint on low-dose rapamycin clinical trial
• medRxiv: Erlangan preprint on BC 007 clinical trial
• The Sick Times: How volunteering to be a lab rat paid off

Additional audio in this episode: 

• Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece)